Peijia Medical
Peijia Medical, officially known as Peijia Medical Technology Co., Ltd., is a leading innovator in the medical device industry, headquartered in China. Founded in 2015, the company has rapidly established itself as a key player in the development of advanced interventional medical devices, particularly in the fields of cardiovascular and neurovascular treatments. With a strong operational presence across Asia and expanding into global markets, Peijia Medical focuses on delivering cutting-edge solutions such as transcatheter aortic valve replacement (TAVR) systems and other minimally invasive technologies. Their commitment to research and development has led to significant milestones, including the successful launch of several proprietary products that enhance patient outcomes. Recognised for its innovative approach, Peijia Medical continues to strengthen its market position, contributing to the evolution of interventional therapies and improving the quality of care for patients worldwide.
DitchCarbon Score
How does Peijia Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Peijia Medical's score of 24 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Peijia Medical's reported carbon emissions
In 2023, Peijia Medical reported total carbon emissions of approximately 6,354,060 kg CO2e. This figure includes about 18,050 kg CO2e from Scope 1 emissions and approximately 6,336,000 kg CO2e from Scope 2 emissions. The company's emissions have increased from 3,612,910 kg CO2e in 2022, which comprised about 6,620 kg CO2e in Scope 1 and approximately 3,606,290 kg CO2e in Scope 2. Over the past few years, Peijia Medical's emissions have shown a significant upward trend, with total emissions rising from about 853,530 kg CO2e in 2020 to 2,847,720 kg CO2e in 2021, and then to 3,612,910 kg CO2e in 2022. The company has not disclosed any specific reduction targets or initiatives aimed at decreasing its carbon footprint, nor has it committed to any science-based targets for emissions reduction. Peijia Medical's emissions data indicates a reliance on energy-intensive operations, as evidenced by the substantial Scope 2 emissions. The absence of Scope 3 emissions data suggests that the company may not be fully accounting for its entire carbon footprint, which typically includes emissions from the supply chain and product use. Overall, while Peijia Medical has made strides in reporting its emissions, the lack of reduction commitments or targets raises questions about its long-term climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 2,120 | 0,000 | 0,000 | 00,000 |
| Scope 2 | 851,410 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Peijia Medical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
